Zhang, Hong-Wei
Fan, Teng
Shen, Dan
Zhao, Zhi-Li
Xi, Hui-Fang
Wang, Wei-Wei
Yue, Xiu-Qin
Li, Li
Article History
Received: 21 October 2024
Accepted: 7 February 2025
First Online: 31 March 2025
Declarations
:
: This randomized, double-blind, controlled study was approved by the Ethics Committee of the First Affiliated Hospital of Xinxiang Medical University (No. EC-023-460). All patients provided written informed consent for participating in the study. The study was registered in the Chinese Clinical Trial Registry (URL: , registration number: ChiCTR2300077933, principal investigator: Hongwei ZHANG, date of registration: November 24, 2023). This study was conducted in accordance with the declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.